Victory Capital Management Inc Foghorn Therapeutics Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
BUY
$7.52 - $18.01 $282,000 - $675,375
37,500 New
37,500 $322,000
Q2 2021

Aug 03, 2021
SELL
$9.32 - $13.26 $150,890 - $214,679
-16,190 Closed
0 $0
Q1 2021

May 04, 2021
SELL
$11.8 - $23.11 $907,184 - $1.78 Million
-76,880 Reduced 82.6%
16,190 $213,000
Q4 2020

Feb 01, 2021
BUY
$15.12 - $25.88 $1.41 Million - $2.41 Million
93,070 New
93,070 $1.89 Million

Others Institutions Holding FHTX

# of Institutions
72
Shares Held
32.7M
Call Options Held
6K
Put Options Held
1.8K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email